These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10291099)

  • 1. Becoming more efficient at outcomes research.
    Roos LL; Sharp SM
    Int J Technol Assess Health Care; 1988; 4(4):555-71. PubMed ID: 10291099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring adverse outcomes of surgery using administrative data.
    Roos LL; Roos NP; Sharp SM
    Health Care Financ Rev; 1987 Dec; Spec No(Suppl):5-16. PubMed ID: 10312320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The critical role of research evidence in the framework of health technology assessment].
    Sauerland S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):251-6. PubMed ID: 16477456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centralization, certification, and monitoring. Readmissions and complications after surgery.
    Roos LL; Cageorge SM; Roos NP; Danzinger R
    Med Care; 1986 Nov; 24(11):1044-66. PubMed ID: 3773578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the impact of new technology: an outcomes-based approach.
    Sachdeva RC
    Crit Care Med; 2001 Aug; 29(8 Suppl):N190-5. PubMed ID: 11496042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease, level of impact, and quality of research methods. Three dimensions of clinical efficacy assessment applied to magnetic resonance imaging.
    Kent DL; Larson EB
    Invest Radiol; 1992 Mar; 27(3):245-54. PubMed ID: 1551777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The method of information synthesis and its use in the assessment of health care technology.
    Marcus SH; Grover PL; Revicki DA
    Int J Technol Assess Health Care; 1987; 3(4):497-508. PubMed ID: 10285720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical technology assessment: adequate questions, appropriate methods, valuable answers.
    Glasser JH; Chrzanowski RS
    Health Policy; 1988; 9(3):267-76. PubMed ID: 10312551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of HTA in German health care. Do we need impact objectives?].
    Gerhardus A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):233-40. PubMed ID: 16453136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring gain in the evaluation of medical technology. The probability of a better outcome.
    Colditz GA; Miller JN; Mosteller F
    Int J Technol Assess Health Care; 1988; 4(4):637-42. PubMed ID: 10291102
    [No Abstract]   [Full Text] [Related]  

  • 11. Net clinical benefit: the art and science of jointly estimating benefits and risks of medical treatment.
    Towse A
    Value Health; 2010 Jun; 13 Suppl 1():S30-2. PubMed ID: 20618793
    [No Abstract]   [Full Text] [Related]  

  • 12. Study design for concurrent development, assessment, and implementation of new diagnostic imaging technology.
    Hunink MG; Krestin GP
    Radiology; 2002 Mar; 222(3):604-14. PubMed ID: 11867773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health economics and HTA].
    Kulp W; Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology assessment in the Connecticut Tumor Registry.
    Wyshak G; Burdick E; Mosteller F
    Int J Technol Assess Health Care; 1991; 7(2):129-33. PubMed ID: 1864696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological studies in the HTA evaluation process].
    Behrens T; Ahrens W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):264-71. PubMed ID: 16477457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a sustainable European Network for Health Technology Assessment. The EUnetHTA project.
    Kristensen FB; Chamova J; Hansen NW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):283-5. PubMed ID: 16453137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of before-after studies of therapeutic impact in the evaluation of diagnostic technologies.
    Guyatt GH; Tugwell PX; Feeny DH; Drummond MF; Haynes RB
    J Chronic Dis; 1986; 39(4):295-304. PubMed ID: 3958116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational model for assessing and evaluating complex interventions in health care.
    May C
    BMC Health Serv Res; 2006 Jul; 6():86. PubMed ID: 16827928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology assessment: approach and reimbursement.
    Yaszemski MJ; Polly DW; Boden SD; Andersson GB
    Spine (Phila Pa 1976); 2007 May; 32(11 Suppl):S39-43. PubMed ID: 17495585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance, technology assessment, and health management: Proteus reborn.
    Rosen H
    J Health Hum Resour Adm; 1982; 5(1):56-70. PubMed ID: 10258784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.